Back
Foghorn Therapeutics, Inc. Stock Predictions
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
45
FHTX
Foghorn Therapeutics, Inc.
Last Price:
$5.73
Seasonality Move:
-12.48%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis NowFoghorn Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Foghorn Therapeutics, Inc. has on average historically fallen by 17.5% based on the past 5 years of stock performance.
-
Foghorn Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Foghorn Therapeutics, Inc. Stock Undervalued?The current Foghorn Therapeutics, Inc. [FHTX] share price is $5.77. The Score for FHTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
FHTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Foghorn Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Foghorn Therapeutics, Inc. has on average historically fallen by 17.5% based on the past 5 years of stock performance.
Foghorn Therapeutics, Inc. Stock Rating
Sell
45
Foghorn Therapeutics, Inc. (FHTX)
is a Sell
Is Foghorn Therapeutics, Inc. overpriced?
-
Foghorn Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Foghorn Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
foghorntx.com
52-Week Data
52-Week High:
6.95
52-Week Low:
2.94
Prediction Charts
Market Cap:
323.8M
Price in USD:
5.77
Volume:
75.5K
Beta:
3.00
Technical Analysis
SMA50:
5.13
SMA100:
4.86
SMA200:
4.82
52-Wk Change:
44.97%
Stock Predictions
-
Is Foghorn Therapeutics, Inc. stock public?Yes, Foghorn Therapeutics, Inc. is a publicly traded company.
-
What is the Foghorn Therapeutics, Inc. stock quote today?The Foghorn Therapeutics, Inc. stock price is 5.77 USD today.
-
How to buy Foghorn Therapeutics, Inc. stock online?You can buy Foghorn Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-9 | 5.26 | 5.16 | 5.30 | 5.04 |
| Jan-12 | 5.42 | 6.38 | 6.50 | 5.40 |
| Jan-13 | 6.46 | 6.68 | 6.95 | 6.09 |
| Jan-14 | 6.61 | 6.31 | 6.81 | 5.89 |
| Jan-15 | 6.31 | 6.28 | 6.58 | 6.01 |
| Jan-16 | 6.27 | 6.02 | 6.43 | 6.00 |
| Jan-20 | 5.84 | 5.57 | 5.99 | 5.55 |
| Jan-21 | 5.64 | 6.08 | 6.09 | 5.62 |
| Jan-22 | 6.08 | 6.20 | 6.29 | 5.95 |
| Jan-23 | 6.18 | 5.88 | 6.18 | 5.85 |
| Jan-26 | 5.87 | 5.81 | 5.99 | 5.74 |
| Jan-27 | 5.78 | 5.90 | 5.95 | 5.73 |
| Jan-28 | 5.92 | 5.87 | 5.94 | 5.69 |
| Jan-29 | 5.83 | 5.77 | 5.93 | 5.68 |
Foghorn Therapeutics, Inc. Earnings
Foghorn Therapeutics, Inc. Earnings Report: Per Share Foghorn Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Foghorn Therapeutics, Inc. Forecast Revenue Growth
Foghorn Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Foghorn Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.10 per share.
* Foghorn Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.